TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01103960 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03802227 — Predictive Biomarker (PRD): NKTR mRNA
Genes: NKTR
Study NCT04676854 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03361423 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study NCT02450838 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03696719 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT03178955 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01586312 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01586312 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03620643 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT03620643 — Predictive Biomarker (PRD): Epithelial cadherin
Genes: CDH1; CDHE; UVO
Study NCT01409681 — Predictive Biomarker (PRD): CYP24A1 mRNA
Genes: CYP24A1; CYP24
Study NCT01409681 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT01330706 — Surrogate Endpoint (SUR): Bacterial count
Study NCT02395016 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02395016 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03957031 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT04045795 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT00319059 — Predictive Biomarker (PRD): AMPD1 mRNA
Genes: AMPD1
Study NCT04088656 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01994590 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT01841320 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02907112 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT02486796 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03244293 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT04156477 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT00798551 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01752348 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT00942773 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT03092908 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02372370 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study NCT01270295 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study NCT01270295 — Predictive Biomarker (PRD): S100A12 mRNA
Genes: S100A12
Study NCT01349556 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01349556 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02797860 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05865054 — Predictive Biomarker (PRD): GCA mRNA
Genes: GCA; GCL
Study NCT03699683 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04060862 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04060862 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04060862 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02963831 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02963831 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04416308 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01675427 — Predictive Biomarker (PRD): IFNL3 mRNA
Genes: IFNL3; IL28B; IL28C; ZCYTO22
Study NCT04218773 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00098098 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00657956 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00739999 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02616848 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT02616848 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01222221 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01222221 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT03919201 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01182857 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study NCT04289727 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03563287 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT03563287 — Predictive Biomarker (PRD): CYP2A6 mRNA
Genes: CYP2A6; CYP2A3
Study NCT03563287 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT03563287 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT03563287 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT03563287 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03563287 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT03563287 — Predictive Biomarker (PRD): CYP2E1 mRNA
Genes: CYP2E1; CYP2E
Study NCT00415350 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00147251 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01373567 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02517866 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02517866 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01417936 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01417936 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02447471 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01270542 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01270542 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02090114 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT02090114 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT02090114 — Pharmacodynamic Biomarker (PDY): Retinoblastoma-associated protein
Genes: RB1
Study NCT00535366 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02628717 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study NCT04031430 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04118933 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT03063203 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT03486613 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02808650 — Predictive Biomarker (PRD): CHEK1 mRNA
Genes: CHEK1; CHK1
Study NCT02044835 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02044835 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03637179 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01672736 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study NCT04871074 — Predictive Biomarker (PRD): SV2A mRNA
Genes: SV2A; KIAA0736; PSEC0174
Study NCT02343120 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT02344771 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04542044 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01641510 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT00935298 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT03872388 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01512381 — Predictive Biomarker (PRD): VSIR mRNA
Genes: VSIR; C10orf54; SISP1; VISTA; PP2135; UNQ730/PRO1412
Study NCT01512381 — Predictive Biomarker (PRD): ESD mRNA
Genes: ESD
Study NCT04373759 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03783975 — Predictive Biomarker (PRD): KCNQ1 mRNA
Genes: KCNQ1; KCNA8; KCNA9; KVLQT1
Study NCT04609969 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00810693 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00810693 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT02629523 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02629523 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02629523 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT01626495 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04148820 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03610451 — Predictive Biomarker (PRD): REST mRNA
Genes: REST; NRSF; XBR
Study NCT02853071 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02853071 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02853071 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02853071 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04901000 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT02660931 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02712671 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02712671 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT01127217 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03912064 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT02321046 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01800799 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT00226798 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01617525 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02479516 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01469234 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03836339 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02674776 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02674776 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03090984 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study NCT03090984 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study NCT00722553 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00319631 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00319631 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00482638 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00440596 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01008813 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03896997 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT01055353 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04298034 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04033510 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05064904 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03078907 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01013948 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03166878 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03166878 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study NCT02571205 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT02571205 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00736294 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04633772 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04633772 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01795638 — Surrogate Endpoint (SUR): Serum sodium
Study NCT00443157 — Surrogate Endpoint (SUR): Serum bactericidal antibody
Study NCT02362737 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04030234 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00019357 — Pharmacodynamic Biomarker (PDY): RAS peptides
Study NCT00019357 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02714010 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05201742 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03520712 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04138069 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04138069 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02527837 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT02527837 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01548872 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT01499069 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT00315536 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02855047 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Placenta growth factor
Genes: PGF; PGFL; PLGF
Study NCT04516369 — Predictive Biomarker (PRD): RPE65 mRNA
Genes: RPE65
Study NCT00684164 — Surrogate Endpoint (SUR): Serum sodium
Study NCT01722396 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT01933711 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT02515643 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03206827 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01242228 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01086605 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00363012 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04500639 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04500639 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01853748 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02329782 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00001137 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03157960 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT03157960 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00303160 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00743197 — Safety Biomarker (SAF): TGFB1
Genes: CED; TGFbeta
Study NCT02727413 — Predictive Biomarker (PRD): CPB1 mRNA
Genes: CPB1; CPB; PCPB
Study NCT02727413 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02727413 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04104334 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00027937 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00027937 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study NCT00027937 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00806715 — Predictive Biomarker (PRD): HFE mRNA
Genes: HFE; HLAH
Study NCT04047732 — Predictive Biomarker (PRD): TGM1 mRNA
Genes: TGM1; KTG
Study NCT04731831 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04731831 — Safety Biomarker (SAF): Human leucocyte antigen
Study NCT02277457 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02277457 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02277457 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03452150 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03452150 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03781544 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01106534 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT02929992 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03180593 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03361358 — Predictive Biomarker (PRD): MTAP mRNA
Genes: MTAP; MSAP
Study NCT05260372 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT00450372 — Safety Biomarker (SAF): Argininosuccinate synthase
Genes: ASS1; ASS
Study NCT00999622 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00999622 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05520385 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study NCT01249859 — Predictive Biomarker (PRD): SRC mRNA
Genes: SRC; SRC1
Study NCT00458861 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02214186 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT02214186 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT04424550 — Predictive Biomarker (PRD): PBK mRNA
Genes: PBK; TOPK
Study NCT01062763 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01669928 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00690222 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02169284 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00250523 — Predictive Biomarker (PRD): IRAK1 mRNA
Genes: IRAK1; IRAK
Study NCT01008150 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02148107 — Predictive Biomarker (PRD): LTA4H mRNA
Genes: LTA4H; LTA4
Study NCT03467477 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT02392611 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03470948 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03845543 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT04281043 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT00545935 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT00317954 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00004464 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02455882 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT02511509 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT02511509 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT02511509 — Safety Biomarker (SAF): BDNF
Study NCT03422263 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT01437956 — Predictive Biomarker (PRD): KL mRNA
Genes: KL
Study NCT01642407 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01558193 — Predictive Biomarker (PRD): DBH mRNA
Genes: DBH
Study NCT01558193 — Predictive Biomarker (PRD): SLC6A3 mRNA
Genes: SLC6A3; DAT1
Study NCT01558193 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT01558193 — Predictive Biomarker (PRD): DRD1 mRNA
Genes: DRD1
Study NCT01558193 — Predictive Biomarker (PRD): DRD2 mRNA
Genes: DRD2
Study NCT01558193 — Predictive Biomarker (PRD): DRD4 mRNA
Genes: DRD4
Study NCT01558193 — Predictive Biomarker (PRD): TPH2 mRNA
Genes: TPH2; NTPH
Study NCT01558193 — Predictive Biomarker (PRD): 5HTT
Genes: SLC6A4; 5-HTT; SERT1
Study NCT01558193 — Predictive Biomarker (PRD): HTR1A mRNA
Genes: HTR1A; ADRB2RL1; ADRBRL1
Study NCT01558193 — Predictive Biomarker (PRD): HTR1B mRNA
Genes: HTR1B; HTR1DB
Study NCT01558193 — Predictive Biomarker (PRD): HTR2A mRNA
Genes: HTR2A; HTR2
Study NCT01558193 — Predictive Biomarker (PRD): HTR2B mRNA
Genes: HTR2B
Study NCT01558193 — Predictive Biomarker (PRD): HTR2C mRNA
Genes: HTR2C; HTR1C
Study NCT01558193 — Predictive Biomarker (PRD): HTR3A mRNA
Genes: HTR3A; 5HT3R; HTR3
Study NCT01558193 — Predictive Biomarker (PRD): HTR4 mRNA
Genes: HTR4
Study NCT01558193 — Predictive Biomarker (PRD): ADRA2A mRNA
Genes: ADRA2A; ADRA2R; ADRAR
Study NCT01558193 — Predictive Biomarker (PRD): ADRB1 mRNA
Genes: ADRB1; ADRB1R; B1AR
Study NCT01558193 — Predictive Biomarker (PRD): ADRB2 mRNA
Genes: ADRB2; ADRB2R; B2AR
Study NCT01558193 — Predictive Biomarker (PRD): ADRB3 mRNA
Genes: ADRB3; ADRB3R; B3AR
Study NCT01558193 — Safety Biomarker (SAF): DRD2
Study NCT01558193 — Safety Biomarker (SAF): DRD3
Study NCT01771380 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT01713699 — Predictive Biomarker (PRD): EPCAM mRNA
Genes: EPCAM; GA733-2; M1S2; M4S1; MIC18; TACSTD1; TROP1
Study NCT02448810 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02448810 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT02883842 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01268150 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01268150 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01140685 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT01527318 — Predictive Biomarker (PRD): PNPLA2 mRNA
Genes: PNPLA2; ATGL; FP17548
Study NCT01527318 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT01147172 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05490771 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT05490771 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT00208949 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03381248 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00674427 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT03313219 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT02606955 — Predictive Biomarker (PRD): REST mRNA
Genes: REST; NRSF; XBR
Study NCT02533648 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT01565174 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT01142505 — Predictive Biomarker (PRD): ALOX5 mRNA
Genes: ALOX5; LOG5
Study NCT00003099 — Predictive Biomarker (PRD): HPR mRNA
Genes: HPR
Study NCT01522833 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01522833 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02163655 — Surrogate Endpoint (SUR): Blood pressure